Brigit Biofarmaka Teknologi Tbk. vs SLJ Global Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while SLJ Global Tbk. trades at Rp106 (market cap 499.34B, 34.05M 24h volume). The key difference: SLJ Global Tbk. is far larger — about 2.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and SLJ Global Tbk. is more actively traded (34.05M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | SULI | |
|---|---|---|
Market Cap | 172.82B | 499.34B |
Volume | 592.2K | 34.05M |
Lot | 5.92K | 340.51K |
Turnover | 147.05M | 3.5B |
Average Price | 248.31 | 102.8 |
Value | 147.05M | 3.5B |
Indicative Equilibrium Price | 254 | 106 |
Indicative Equilibrium Volume | 10 | 40.32K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT SLJ Global (the Company) was established under the name of PT. Sumalindo Lestari Jaya in the Republic of Indonesia based on Notarial Deed No. 10 dated April 14, 1980, of Rukmasanti Hardjasatya , S.H., as amended by Deed No. 1 dated June 3, 1980, of the same notary.
Read more on SULI →